{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:40:06Z","timestamp":1756294806577,"version":"3.44.0"},"reference-count":11,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>\n                  <jats:sc>l<\/jats:sc>-2 Hydroxyglutaric aciduria is a rare autosomal recessively inherited metabolic disorder of organic acid metabolism. Cerebellar and pyramidal signs with progressive neurological syndromes, mental deterioration, tremors, seizures, epilepsy and rarely macrocephaly are clinical findings of the disease. The diagnosis depends on increased levels of <jats:sc>l<\/jats:sc>-2 hydroxyglutaric acid in urine, plasma and cerebrospinal fluid. Brain MRI shows peripheral white matter abnormalities in cerebral hemispheres, bilateral symmetrically abnormal signal intensity in basal ganglia and dentate nuclei. In this case report, we present a 13-year-old patient who presented with tremors and anxiety symptoms and was diagnosed as <jats:sc>l<\/jats:sc>-2 hydroxyglutaric aciduria after consultation with the child neurology department. We present a patient suffering from psychiatric symptoms with a metabolic disorder.<\/jats:p>","DOI":"10.1136\/bcr-2013-009512","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T23:36:13Z","timestamp":1370561773000},"page":"bcr2013009512","source":"Crossref","is-referenced-by-count":6,"title":["l-2 Hydroxyglutaric aciduria presenting with anxiety symptoms"],"prefix":"10.1136","volume":"2013","author":[{"given":"Cem","family":"G\u00f6k\u00e7en","sequence":"first","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, Gaziantep University, Gaziantep, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedat","family":"I\u015fikay","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Gaziantep Children's Hospital, Gaziantep, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kutluhan","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Neurology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,6,6]]},"reference":[{"key":"2025082703583845000_2013.jun06_1.bcr2013009512.1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02312543","article-title":"L-2-Hydroxyglutaric aciduria: an inborn error of metabolism?","volume":"2013","author":"Duran","year":"1980","journal-title":"J Inherit Metab Dis"},{"key":"2025082703583845000_2013.jun06_1.bcr2013009512.2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2008-1081217","article-title":"L-2-hydroxyglutaric aciduria and brain tumors in children with mutations in the L2HGDH gene: neuroimaging findings","volume":"2013","author":"Haliloglu","year":"2008","journal-title":"Neuropediatrics"},{"key":"2025082703583845000_2013.jun06_1.bcr2013009512.3","first-page":"1","article-title":"L-2-hydroxyglutaric aciduria: a report of 29 patients","volume":"2013","author":"Top\u00e7u","year":"2005","journal-title":"Turk J Pediatr"},{"key":"2025082703583845000_2013.jun06_1.bcr2013009512.4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s100720070104","article-title":"Clinical, biochemical and neuroradiological findings in L-2-hydroxyglutaric aciduria","volume":"2013","author":"Moroni","year":"2000","journal-title":"Neurol Sci"},{"key":"2025082703583845000_2013.jun06_1.bcr2013009512.5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pediatrneurol.2012.01.008","article-title":"Eyelid myoclonia with absence seizures in a child with l-2 hydroxyglutaric aciduria: findings of magnetic resonance imaging","volume":"2013","author":"Mete","year":"2012","journal-title":"Pediatr Neurol"},{"key":"2025082703583845000_2013.jun06_1.bcr2013009512.6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0387-7604(01)00206-6","article-title":"L-2-Hydroxyglutaric aciduria presenting as status epilepticus","volume":"2013","author":"Zafeiriou","year":"2001","journal-title":"Brain Dev"},{"key":"2025082703583845000_2013.jun06_1.bcr2013009512.7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1148\/radiol.2513080647","article-title":"L-2-Hydroxyglutaric aciduria: pattern of MR imaging abnormalities in 56 patients","volume":"2013","author":"Steenweg","year":"2009","journal-title":"Radiology"},{"key":"2025082703583845000_2013.jun06_1.bcr2013009512.8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.braindev.2007.09.005","article-title":"L-2-Hydroxyglutaric aciduria presenting with severe autistic features","volume":"2013","author":"Zafeiriou","year":"2008","journal-title":"Brain Dev"},{"key":"2025082703583845000_2013.jun06_1.bcr2013009512.9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/088307389601100505","article-title":"Clinical and magnetic resonance imaging features of L-2-hydroxyglutaric acidemia: report of three cases in comparison with Canavan disease","volume":"2013","author":"Top\u00e7u","year":"1996","journal-title":"J Child Neurol"},{"key":"2025082703583845000_2013.jun06_1.bcr2013009512.10","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/hmg\/ddh300","article-title":"L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1","volume":"2013","author":"Top\u00e7u","year":"2004","journal-title":"Hum Mol Genet"},{"key":"2025082703583845000_2013.jun06_1.bcr2013009512.11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejpn.2008.01.003","article-title":"Riboflavin treatment in a case with L-2-hydroxyglutaric aciduria","volume":"2013","author":"Yilmaz","year":"2009","journal-title":"Eur J Paediatr Neurol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-009512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:58:50Z","timestamp":1756292330000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-009512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,6]]},"references-count":11,"alternative-id":["10.1136\/bcr-2013-009512"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-009512","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2013,6,6]]}}}